ParkinSense System for Parkinson's Disease

This trial tests a device called the ParkinSense system to determine its effectiveness for people with Parkinson's disease who experience freezing of gait, a condition where the feet feel stuck to the ground. The trial will assess whether using the system reduces the time spent frozen compared to not using it. Participants will initially try the system in a lab and then use it at home for two weeks. Candidates may be suitable if they have been diagnosed with Parkinson's disease, experience freezing of gait, and can still walk. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance daily life for those with Parkinson's disease.

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but it's best to confirm with the trial organizers.

Research has shown that the ParkinSense system could be a helpful new tool for people with Parkinson's disease. However, detailed safety information specifically for the ParkinSense system is not yet available. The trial is in an early phase, so few studies have examined its safety so far. The trial's progression suggests that early tests or prototypes have not revealed major safety concerns.

Unlike traditional treatments for Parkinson's disease, which often involve medications like Levodopa to manage symptoms, the ParkinSense System is a non-invasive wearable device. Researchers are excited about this approach because it specifically targets freezing of gait (FOG), a common and challenging symptom of Parkinson's, by potentially providing real-time feedback and cues to help patients regain mobility. This system could offer a new way to manage FOG without relying on medications, possibly reducing side effects and improving quality of life for patients.

Studies have shown that systems like ParkinSense can effectively measure and monitor symptoms of Parkinson's disease, such as difficulty walking. In this trial, participants will experience two different sequences: one group will use the ParkinSense System first, followed by a control period without it, while the other group will start with the control period and then use the ParkinSense System. The PKG (Personal KinetiGraph) device, which is similar, accurately tracks several Parkinson's symptoms, suggesting ParkinSense might work just as well. Testing these systems in real-life settings has demonstrated their effectiveness in patients' daily lives. This technology shows promise for managing Parkinson's symptoms and could help reduce the time patients have difficulty walking. Overall, early signs are positive for using these systems to help manage Parkinson's symptoms.⁶⁷⁸⁹¹⁰